
Apart from becoming the world's largest supplier of pharmaceuticals, India is fast becoming a global clinical trial hub. With clinical trials being conducted at a fraction of the cost of US trials, it is becoming an attractive option for biopharma companies. Whether it is first-in-human safety/efficacy data that you are trying to generate to attract investors, or a label-expansion/Phase IV study, India might be your answer. Let's talk!